# OnCo record paper-subbiah-dabrafenib-trametinib-atc-jco-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-subbiah-dabrafenib-trametinib-atc-jco-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-subbiah-dabrafenib-trametinib-atc-jco-2018" ;
  schema:name "Dabrafenib and trametinib in BRAF V600E-mutant anaplastic thyroid cancer (ROAR)"@en ;
  schema:description "In one of the most lethal cancers known, dabrafenib plus trametinib shrank BRAF-mutant anaplastic thyroid cancer in about two thirds of patients, leading to the first ever drug approval for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-subbiah-dabrafenib-trametinib-atc-jco-2018/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2017.73.6785>, <https://pubmed.ncbi.nlm.nih.gov/29072975/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2017.73.6785> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Subbiah V, Kreitman RJ, Wainberg ZA, et al." ;
  onco:cancers <https://onco.cc/cancers/anaplastic-thyroid-cancer/> ;
  onco:drugs <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/trametinib/> ;
  onco:journals <https://onco.cc/journals/jco/> .